Loading company…
Nanomics develops proteomics platforms and tools for biomarker and drug discovery research.
Established in 2021, Nanomics is based in Hangzhou, China, and develops high-throughput proteomics technologies. Its Kepler Pro platform combines microfluidics, automated sample processing, nanoprobe analysis, and bioinformatics. The company provides testing reagents, consumables, automation workstations, and proteomics platforms to researchers.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in